iPSC Bank

iPSC Bank is a leading biotechnology research company focused on cell banking and advanced therapeutic solutions. As a subsidiary of CytoMed Therapeutics, iPSC Bank specializes in banking various cell types, including PBMCs, iPSCs, and MSCs, ensuring their availability for future use in cutting-edge medical applications.

Located in Singapore, iPSC Bank leverages the expertise and patented technologies of its parent company, CytoMed Therapeutics, to develop innovative “off-the-shelf” immunotherapeutics targeting a wide range of cancers. CytoMed Therapeutics, established in 2018, is dedicated to translating technological advancements into practical cellular therapies.

iPSC Bank, with its state-of-the-art GMP facility, supports comprehensive cell therapies and banking activities, ensuring the highest standards of quality and safety. The primary address for iPSC Bank is in Singapore, SG. We invite the management of iPSC Bank to enhance this profile further with a customized and exclusive company showcase and product listing on our platform.